Amicus Therapeutics Inc.

7.95
-0.21 (-2.57%)
At close: Apr 01, 2025, 3:59 PM
8.05
1.34%
After-hours: Apr 01, 2025, 07:41 PM EDT

Amicus Therapeutics Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Net Income -56.11M -151.58M -236.57M -250.46M -276.85M -356.39M -349M -284M -200.04M -132.12M -68.93M -59.63M -48.78M -44.41M -54.94M -6.57M -39.35M -41.17M -46.34M -19.97M
Depreciation & Amortization 2.26M 7.87M 5.34M 6.21M 8.85M 4.78M 4.22M 3.59M 3.24M 1.83M 1.55M 1.72M 1.71M 1.58M 2.06M 2.13M 1.49M 1.24M 952.45K 667.38K
Stock-Based Compensation 84.91M 86.08M 76.51M 57.84M 49.15M 44.43M 29.26M 23.1M 17.5M 9.97M 6.01M 6.18M 6.19M 8.68M 6.19M 7.79M 6.45M 2.82M n/a n/a
Other Working Capital n/a -32.46M -10.83M -10.04M -5.6M -18.9M -4.34M -29.73M -926K -1.13M -157K 6.26M 3.18M -11.16M 32.52M -45.25M -3.82M 44.4M 6.97M 788.61K
Other Non-Cash Items -64.95M 41.47M 28.01M 2.47M 17.78M 46.57M 14.28M 234.91M 31.37M 4.88M 314K 1.99M -625K -2.76M 1.41M 195K 6.45M 4.13M 4.53M 391.94K
Deferred Income Tax n/a -4.94M 9K 34K -155K -1.42M 6.01M -167.31M -3.74M 952K n/a -908K n/a n/a 121K n/a -6.4M -2.82M n/a n/a
Change in Working Capital n/a -47.99M -39.88M -18.59M -32.06M 11.61M -4.73M -25.79M 1.14M 14.34M 9.39M 4.86M 7.77M -12.51M 31.18M -46.92M -5.49M 50.99M 6.97M 788.61K
Operating Cash Flow -33.89M -69.09M -166.57M -202.49M -233.29M -250.42M -299.95M -215.49M -150.53M -100.14M -51.67M -45.79M -33.74M -49.42M -13.98M -43.37M -36.86M 15.19M -33.89M -18.12M
Capital Expenditures -3.55M -7.44M -3.77M -3.88M -3.23M -20.01M -6.31M -4.53M -5.95M -4.82M -238K -695K -4.32M -1.42M -384K -1.81M -2.67M -669K -2.03M -3.04M
Acquisitions n/a n/a 3.41M 3.88M 3.23M 20.01M 6.31M n/a n/a -141.06M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -114.79M -91.72M -243.25M -341.4M -365.18M -383.88M -578.39M -490.47M -219.93M -289.6M -162.75M -56.56M -118.46M -50.6M -113.66M -98.17M -153.69M -200.74M -62.01M -16.99M
Sales Maturities Of Investments 117.78M 197.23M 335.93M 424.04M 354.83M 499.05M 463.5M 323.75M 221.37M 290.13M 55.91M 83.34M 83.35M 98.47M 94.6M 131.85M 178.1M 126.37M 37.44M 3.09M
Other Investing Acitivies n/a n/a 3.41M -3.88M -3.23M -20.01M -6.31M -166.72M 1.44M 534K -106.84M 26.78M -35.11M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -560K 98.06M 92.32M 78.76M -13.58M 95.15M -121.2M -171.24M -4.51M -145.34M -107.08M 26.08M -39.43M 46.45M -19.44M 31.87M 21.75M -75.04M -26.6M -16.94M
Debt Repayment -97K -20.96M -283K -479K 230.6M 19.45M 146.26M -308K 192.34M 34.71M -299K 14.49M -347K -1.29M -1.56M 2.71M -1.53M -1.39M -880.75K -272.7K
Common Stock Repurchased n/a n/a -11.49M n/a -10.03M -3.23M -2.83M -1.6M -1.28M -2.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 5.22M -20.57M n/a 12.8M 32.25M 9.05M 9.93M 4.71M -16.7M 13.14M 3.67M -110K 1.63M 359K 9K 60K n/a 546K 3.43M 1.11M
Financial Cash Flow 5.12M 61.68M -7.46M 212.07M 262.86M 217.5M 450.77M 247.43M 272.71M 290.89M 139.18M 29.38M 81.48M -934K 43.66M 2.77M -998K 91.91M 66.17M 41.25M
Net Cash Flow -33.36M 96.96M -96.34M 83.29M 19.82M 63.97M 31.14M -137.97M 117.54M 45.41M -19.57M 9.67M 8.3M -3.9M 10.23M -8.73M -16.11M 32.06M 5.68M 6.19M
Free Cash Flow -37.44M -76.53M -170.34M -206.38M -236.52M -270.43M -306.26M -220.01M -156.49M -104.96M -51.91M -46.49M -38.07M -50.84M -14.37M -45.18M -39.53M 14.52M -35.92M -21.16M